3Meager A, Biological assays for interferons, Journal of Immunological Methods. 2002 261(1/2): 21-36.
4Johnson H M, Bazer F W, Szente B E, Jarpe M A. How interferons fight disease. Scientific American, 1994, 270(5): 68-75.
5Taguchi T. lnterleukin-2 (IL-2). Gan To Kagaku Rvoho 1994, 21(5): 719-724.
6Tossing G. Interferon-alpha in treatment of chronic hepatitis C in co-infecled HIV-patients in combination with ribavirin and as a pre-load therapy in treatment-naive HIV-positive patients. 8th European Conference on clinical aspects and treatment of HIV infection (Sth ECCATH), 29-31 October, Athens Greece. European Journal of Medical Research, 2002, 7(1): 44-46.
7Robak T. Biological properties and therapeutic use of interleukin 2 (IL-2). Postepy Higieny Medycyny Doswiadczabej, 1995, 49(3): 367-393.
8Prentice H G, Macdonald 1 D, Hamon M D. The role of immunotherapy in the treatment of acute myeloblastic leukemia: from allogeneic bone marrow transplantation to the application of interleukin 2. Cancer Treatment and Research, 1993, 64:121-134.
9Reier A, Mitsuyasu RT. Use of interleukin-2 in immunotherapy of human immunodeficiency virus infection. BioDrugs, 1998, 10(3): 215-225.
10Sekellick M J, Ferrandino A IF, Hopkins D A, Marcus P I. Chicken interferon gene: cloning, expression, and analysis. Journal of lnterfervn Research, 1994, 14(2): 71-79.
